NDA-22-291---FDA市公开课一等奖课件名师大赛获奖课件.pptx

NDA-22-291---FDA市公开课一等奖课件名师大赛获奖课件.pptx

  1. 1、本文档共43页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多

NDA22-291PROMACTA?(Eltrombopag)FDAReviewAndrewDmytrijuk,MD1

ProposedIndication Eltrombopagisindicatedfortheshort-termtreatmentofpreviously-treatedpatientswithchronicidiopathicthrombocytopenicpurpura(ITP)toincreaseplateletcountsandreduceorpreventbleeding.Underlinesaddedforemphasis2

EltrombopagBackgroundTablet,administereddailyBindstotransmembraneportionofTPO receptorPreclinicaltestingofEltrombopag:stimulatedplateletsonlyinchimpanzeesinotheranimals(inhighdoses):ChronicprogressivenephropathyLiverabnormalitiesCataractsPreclinicaltestingofanotherTPO receptoragonist:marrowfibrosis3

ClinicalDatabase

Eltrombopag(E)exposuren=1088ChronicITP:n=330ThrombocytopeniainhepatitisC:n=56Chemotherapy-inducedthrombocytopenia:n=134Clinicalpharmacology:N=5684

ITPProgram“Shortterm”:6weekexposure-Completed:placebocontrolled -773A -773B-On-going,singlearm:“REPEAT” “Longterm”:≥6monthexposure-On-going:placebocontrolled:“RAISE”-On-going:singlearm:“EXTEND”5

MajorReviewTopics:“ShortTerm”Efficacy:increaseplateletcountsreduceorpreventbleedingSafety:bleedingrisksfollowingdrugdiscontinuationhepatotoxicity“shortterm”indicationbutlongtermusage -morehepatotoxicity? -potentialmarrowfibrosis?6

DataPresentationCompletedstudies(short-term):773A773BOn-goingstudies/interim:REPEAT(cyclesofshort-term)EXTENDRAISE7

“ShortTerm”Rationale:

Protocols “ShorttermtreatmentmayincreaseplateletcountsinpatientswithchronicITPscheduledforsurgicalordentalprocedures,wherealowplateletcountcanbeahindranceorevenprohibitiveoftheprocedureduetotheriskofexcessivebleeding.”Underlinesaddedforemphasis8

Studies773Aand773B:DesignFeaturesDB,PC,multi-nationalEligibility:-platelets30Kdespiteatleast1priortherapy-didnotselectpatientsscheduledforproceduresRandomization:-773A:placebooractivedrugat

文档评论(0)

+ 关注
实名认证
内容提供者

好文档 大家想

1亿VIP精品文档

相关文档